Sodium Pyroglutamate
PreliminaryMechanism of Action
Research Notes
Anti-angiogenic and immune-protective activity was demonstrated in Lewis lung carcinoma mouse models, where oral sodium pyroglutamate supplementation reduced tumor vascularity and maintained cytotoxic T-cell function. The compound showed particular efficacy in pre-initiation protection paradigms. No human clinical trials have been conducted.
Found In 1 Herb
3D Molecular Structure
Sodium Pyroglutamate
Representative pattern: C₄H₂NO
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
